*2.6. Cell Viability Assay*

The viability of the cells was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) colorimetric assay (Sigma-Aldrich, St. Louis, MO, USA). The 2 × 104–4 × 104 cells/mL were seeded in 96-well plates. After the attachment, cells were treated with different concentrations of **B**, EL000327, D, and 5-FU for 48 h in the presence or absence of various inhibitors (Z-VAD-FMK (10 μM) (R&D System, Inc, McKinley Place N.E, MN, USA), 3-MA (1mM), CQ (10 μM), NAC (5 mM) (Sigma-Aldrich, St. Louis, MO, USA), and SP600125 (10 μM) (Cell Signaling Technology, MA, USA). Cells treated with 0.01% of DMSO were used as the control. Next, 15 μL of the MTT reagent was added to each well and incubated for 4 h at 37 ◦C. The medium was aspirated completely and 150 μL of DMSO (Sigma-Aldrich, St. Louis, MO, USA) was added to the cells before the absorbance was measured at 540 nm by a microplate reader (Bio Tek Instruments, Winooskim, VT, USA) using Gen 5 (2.03.1) software. SPSS statistical software 23 was used for the IC50 calculation. Synergic effects of **B** with D or 5-FU were assessed by compuSyn software.

#### *2.7. Cell Cycle Analysis by Flow Cytometry*

Caco2, HCT116, DLD1, and HT29 cells were seeded in 6-well plates at the density of 1.5–2 × 105 cells/well, incubated overnight, and treated with 0.01% of DMSO, various concentrations of **B**, and 60 μg/mL of EL000327 for 24 h, 48 h, or 72 h. Cells were harvested and washed with FACS washing buffer, incubated with trypsin solution, followed by RNase A for 10 min at room temperature. Cells were centrifuged and pellets were collected and stained with 100 mL of 4 mg/mL PI (Sigma-Aldrich, St. Louis, MO, USA) for 2 h in the dark at 4 ◦C. Cell cycle analysis was performed on a CytoFLEX instrument (Beckman Coulter Life Sciences, Indianapolis, IN, USA).

#### *2.8. Western Blotting*

Caco2 cells were cultured in 6-well plates at the density of 2 × 105 cells/well overnight and treated with 0.01% of DMSO, different concentrations of **B**, and 60 μg/mL of EL000327 for 24 h or 48 h in the presence or absence of various inhibitors (Z-VAD-FMK (10 μM), 3-MA (1 mM), CQ (10 μM), NAC (5 mM), and SP600125 (10 μM). Cells were harvested and lysed, and the protein concentrations were determined by the BCA protein assay following the manufacturer's instructions. Then, 25 or 50 μg of the total extract was separated by SDS-PAGE (12%) and transferred to a blotting membrane at 1.2 A for 6 h. Membranes were blocked with 5% of skim milk for 1 h followed by incubation with various primary antibodies (Cyclin B1, D1, p-Cdc2, BAX, Bcl-XL, PARP, caspase-3, Beclin 1, P-62, LC3B I/II, p-JNK, JNK, p-Akt, Akt, NF-κB, Actin purchased from Cell Signaling Technology, MA, USA) for 2 h at room temperature (RT). Blots were washed and incubated with horseradish peroxidase-conjugated secondary antibodies (Thermo Fisher Scientific, Waltham, MA, USA) for 30 to 60 min at RT. Specific antibody binding was detected under chemiluminescence imaging (iBright FL1000 Imaging System, Thermo Fisher Sciences, biomolecular imager, Amersham ImageQuantTM 800 Western Blot Imaging System) and measured by Multi Gauge 3.0. software. Relative density was calculated against the density of the actin bands.

#### *2.9. Tubulin Polymerization Assay*

The effect of **B** on tubulin organization was detected using the Tubulin Polymerization Assay Kit (Cytoskeleton, Inc., Denver, CO, USA) according to the manufacturer's instructions. In brief, tubulin proteins (>99% pure) were suspended at a final concentration of 3.0 mg/mL in ice-cold TP, and the tubulin solution was incubated at 37 ◦C with a general tubulin buffer with or without **B** (3.3, 20, 60 μg/mL). Paclitaxel and vinblastine (10 μM) were used as positive controls for the stabilization or destabilization of the microtubules, respectively. Tubulin polymerization was measured by continuously monitoring the change in turbidity at 340 nm by a microplate reader using Gen 5 (2.03.1) software.

#### *2.10. Quantitative Real-Time PCR*

Total RNA of 0.01% of DMSO, **B** (20, 60 μg/mL), and EL000327 (60 μg/mL) treated Caco2 cells were extracted using RNAiso Plus (TaKaRa, Kusatsu, Shiga, Japan) according to the manufacturer's instructions. cDNA was reverse transcribed from 3 μg of total RNA of each treated group using the M-MLV Reverse Transcriptase Kit (Invitrogen, Carlsbad, CA, USA). mRNA levels of stathmin and MAP4 was measured using stathmin (forward) 5-GGTGGCGGCAGGACTTTCCTTATCCCAGTTGATT-3 and (reverse) 5- TTCTCGTGCTCTCGTTTCTCAGCCAGCTGCTTC-3; MAP4 (forward) 5-CCCTTTCTGAG GTAGCGTGCCTTGTGGAGGT -3 and (reverse) 5-CTGGCTCCCTCATGTTCTTGGCACAG CAGA-3 primers and SYBR green (Enzynomics). qRT-PCR reaction and analysis were performed using CFX (Bio-Rad, Hercules, CA, USA).

#### *2.11. Immunofluorescence (IF) Imaging*

Caco2 cells were cultured on cover slips at the density of 1 × 105 in a 12-well plate. After the adherence, cells were treated with 0.01% of DMSO, different concentrations of **B**, paclitaxel (100 nM), vinblastine (50 nM), and deoxyphodophyllotoxin (DPT) (25 nM) for 24 h. Cells were washed with phosphate-buffered saline (PBS) three times, followed by fixation with 4% paraformaldehyde in PBS for 10 min, permeabilization with 0.1% Triton™ X-100 for 10 min at RT, and blocking with 1% BSA in PBS for 1 h at RT. The cells were labeled with alpha tubulin (B-5-1-2) Alexa Fluor 488 Mouse Monoclonal Antibody, at 2 μg/mL in 0.1% BSA, and incubated for 3 h at RT. Cells were washed three times with PBS for 5 min after every step. Then, the cells were blocked again with blocking solution containing 1% BSA for 30–45 min at RT. Cells were stained again with fluorescent phalloidin staining solution and incubated for 30–60 min at RT. After washing with PBS, cover slips were mounted on glass slides with prolong gold with DAPI and left overnight at RT. Images were taken using a K1-Fluo Confocal Laser Scanning Microscope (Nanoscope Systems, Daejeon, Republic of Korea).

#### *2.12. Hoechst Staining*

Caco2, HCT116, DLD1, and HT29 cells were seeded in a 12-well plate containing cover slips at a density of 1 × 105 cells/well. After overnight incubation, cells were treated with 0.01% of DMSO, **B** (20, 60 μg/mL), and EL000327 (60 μg/mL) for 12 or 24 h. Cells were washed with PBS, followed by fixation with 4% paraformaldehyde for 15 min. After washing again with PBS, cells were permeabilized in 0.1% Triton X-100 (Sigma-Aldrich) for 30 min, and stained with Hoechst 33258 (Sigma-Aldrich) for 1 h in the dark at room temperature. Cells were assessed by Nikon Eclipse 400 fluorescence microscope (Nikon Instech Co. Ltd., Kawasaki, Japan) to identify the morphological changers in the nuclei.

#### *2.13. IncuCyte™ Caspase-3/7 and Annexin v Apoptosis Assay*

Caco2 cells were seeded in a 96-well plate at a density of 2.5 × 103 cells/well. Cells were grown overnight to 25–30% confluence at the start of the assay. Media were supplemented with 5 μM of Caspase-3/7 (green) reagent (4440, Essen Bioscience, Morgan Rd, Ann Arbor, MI, USA) or Annexin V (red) reagent (4641, Essen Bioscience, Morgan Rd, Ann Arbor, MI, USA) diluted to 1:200 and added to the cells treated with 0.01% of

DMSO, different concentrations of **B**, and EL000327 for 48 h in the presence or absence of Z-VAD-FMK (10 μM). The apoptosis of cells was determined by fluorescence scanning performed every 2 h for 48 h by the IncuCyte Zoom® instrument with a 10× objective and analyzed with the Standard Scan Type.

#### *2.14. Apoptosis Analysis by Flow Cytometry*

Caco2, HCT116, DLD1, and HT29 cells were cultured in a 6-well plate at the density of 2 × 105 cells/well until adherence. Cells were treated with 0.01% of DMSO, different concentrations of **B**, and EL000327 for 48 h in the presence or absence of Z-VAD-FMK (10 μM). Cells were harvested and washed with PBS, resuspended in 100 μL of 1x binding buffer followed by staining with 5 μL of 50 μg/mL propidium iodide (PI; BD Biosciences, San Jose, CA, USA) and 3 μL of Annexin V–FITC (BD, Biosciences, San Jose, CA, USA), for 30 min in the dark. Death cells were detected by flow cytometry on a CytoFLEX instrument (Beckman Coulter Life Sciences, Indianapolis, IN, USA).

#### *2.15. Measurement of ROS Generation*

Caco2 cells were seeded in a 6-well plate at the density of 2 × 105 cells/well overnight and treated with 0.01% of DMSO, different concentrations of **B**, and EL000327 for 12 h in the presence or absence of NAC (5 mM). Cells were incubated with DCFH-DA (10 μM) in DMEM medium without FBS for 30 min at 37 ◦C and washed three times with DMEM. ROS generation was determined by fluorescence microscopy (K1-Fluo Confocal Laser Scanning Microscope, Nanoscope Systems, Daejeon, Republic of Korea) and flow cytometry (CytoFLEX; Beckman Coulter Life Sciences, Indianapolis, IN, USA) using peroxide-sensitive fluorescence probe DCFH-DA.


**2.6. Detection of amino acid substitutions related to IRRDR in NS5A of HCV-G1b**

Nucleotide sequences of NS5A-IRRDR were analyzed by direct sequencing after doubleround PCR according to El-Shamy et al. [34] and the numbers of aa substitutions within this region (2334-2376) determined. Moreover, the particular position of aa substitutions were evaluated in connection to dyslipoproteinemia, found in chronic HCV-G1b patients.


*Article* **The Functional Relevance of Di**ff**usion Tensor Imaging in Patients with Degenerative Cervical Myelopathy**

**Stefania d'Avanzo 1,\*,**†**, Marco Ciavarro 2,**†**, Luigi Pavone 2, Gabriele Pasqua 3,4, Francesco Ricciardi 2, Marcello Bartolo 2, Domenico Solari 1, Teresa Somma 1, Oreste de Divitiis 1, Paolo Cappabianca 1 and Gualtiero Innocenzi 2**

Received: 8 May 2020; Accepted: 8 June 2020; Published: 11 June 2020

**Abstract:** (1) Background: In addition to conventional magnetic resonance imaging (MRI), diffusion tensor imaging (DTI) has been investigated as a potential diagnostic and predictive tool for patients with degenerative cervical myelopathy (DCM). In this preliminary study, we evaluated the use of quantitative DTI in the clinical practice as a possible measure to correlate with upper limbs function. (2) Methods: A total of 11 patients were enrolled in this prospective observational study. Fractional anisotropy (FA) values was extracted from DTI data before and after surgery using a GE Signa 1.5 T MRI scanner. The Nine-Hole Peg Test and a digital dynamometer were used to measure dexterity and hand strength, respectively. (3) Results: We found a significant increase of FA values after surgery, in particular below the most compressed level (*p* = 0.044) as well as an improvement in postoperative dexterity and hand strength. Postoperative FA values moderately correlate with hand dexterity (r = 0.4272, R2 = 0.0735, *p* = 0.19 for the right hand; r = 0.2087, R2 = 0.2265, *p* = 0.53 for the left hand). (4) Conclusion: FA may be used as a marker of myelopathy and could represent a promising diagnostic value in patients affected by DCM. Surgical decompression can improve the clinical outcome of these patients, especially in terms of the control of finger-hand coordination and dexterity.

**Keywords:** diffusion tensor imaging (DTI); fractional anisotropy (FA); cervical MRI; degenerative cervical myelopathy (DCM); myelopathy hand

### **1. Introduction**

Degenerative cervical myelopathy (DCM) is the most common non-traumatic spinal cord disorder in patients over 55 years old [1–4]: It is a progressive spinal cord disease characterized by degenerative changes of the bone, ligaments and intervertebral disc of cervical spine [5,6].

DCM comprises a wide set of clinical features, including neck pain, motor and sensory deficits and bladder dysfunction [7,8]. Furthermore, peculiar loss of strength and hand dexterity (the so-called "clumsy hand" or "myelopathy hand") is observed in patients with DCM. Ono et al. [8] first reported a loss of intensity of adduction and extension in the ulnar of two or three fingers and an inability to grip and release rapidly with these fingers. Furthermore, the occurrence of "myelopathy hand" has been demonstrated to be a crucial clinical sign to achieve an early suspicion of pyramidal tract damage [9–11].

Conventional T2-weighted magnetic resonance imaging (T2WI) is an integral part of DCM patient evaluation. There is some evidence from a largest prospective multicenter magnetic resonance imaging (MRI) study that signal changes have some relevance in terms of its correlation with baseline and outcome. T2WI shows an increased signal intensity in the compressed part of the spinal cord; however, this abnormal MR signal has low sensitivity for structural change of the cord in cervical myelopathy and it is not predictive of neurological function before and after surgical treatment [12–17].

Diffusion tensor imaging (DTI) is an advanced imaging technique that has been proposed to assess DCM-associated demyelination and axonal damage. DTI provides also quantitative information about the white matter microarchitecture. Fractional anisotropy (FA) is a quantitative DTI parameter that measures the tendency of water to spread in a preferred direction within a group of axons and it is a function of the axonal density and integrity of white matter fibers as well as the degree of myelination [18–20]. Normative values of FA for healthy subjects were found to be 0.68 ± 0.05, after correcting for age and sex. Hence, a decrease of FA value highlights fiber tracts impairment. Several studies showed significant decrease of FA values at the most compressed level, but also at distant areas [21,22].

DTI values, as compared to conventional MRI, are more sensitive in the detection of DCM patients, especially in the early stage of the disease; quantitative analysis of its parameters helps in the definition of myelopathy severity and can predict the outcomes of surgical treatments [23–26].

In this study, we aimed to define the diagnostic value of quantitative DTI in patients with DCM, measuring the correlation between the FA values and hand-motor performance, i.e., dexterity and hand strength—as measured via function test batteries, thus determining its functional relevance.

### **2. Experimental Section**

### *2.1. Participants*

This is a prospective observational study reporting preliminary data on 11 patients (6 females and 5 males; mean age 57.64 ± 10.47 years). All subjects included in the sample were diagnosed with degenerative cervical myelopathy, as well as with myelopathic hand. The severity of cervical myelopathy was assessed using the modified Japanese Orthopedic Association (mJOA) score [27]. Each patient underwent surgery via anterior cervical discectomy and fusion (ACDF) at the I.R.C.C.S. Neuromed di Pozzilli (Isernia, Italy). A 1.5 T MRI scan from 24 to 48 h prior to the surgery and another MRI scan 3 months after the surgery were acquired for each patient. In order to evaluate the severity of the clumsy hand, the measurement of strength and hand dexterity was performed the same day of the MRI scans. Patients with cerebral palsy, rheumatoid arthritis or other spinal diseases were excluded from this study. Protocol was approved by the Ethical Committee of the I.R.C.C.S. Neuromed (Ethical Approval Code: 11/17 21-12-2017).

### *2.2. Di*ff*usion Tensor Imaging (DTI) Acquisition and Analysis*

In order to study and quantify changes in white matter structural integrity, patients underwent a cervical MRI scan with Diffusion Tensor Imaging (DTI), with a focus at the pathological segment, 24–48 h before and three months after the surgery. A GE Signa 1.5 T MRI scanner was used to acquire MRI data. The MRI protocol included Structural 2D T2-weighted images (Slice Thickness 4 mm, Repetition Time 6700 ms, Echo Time 95.9 ms, Matrix Size 320 × 224, Field of View 220 mm, Flip Angle 90◦) acquired both in the axial and sagittal plane, and DTI images with 16 diffusion directions (b = 1000 s/mm2, 1b0, Repetition Time 10,000 ms, Echo Time 100 ms, Matrix Size 92 × 64). Image

analysis was performed using the 3D Slicer software [28] and Fractional Anisotropy (FA) was extracted from DTI data [29,30]. Image processing pipeline comprised registration of anatomical T2WI with DTI images, using a 27 degrees of freedom BSpline registration. The accuracy of registration was visually assessed by a neuroradiologist (MB). Different Regions of Interest (ROIs), using the T2 images as reference, were created on a color-coded FA map in correspondence of the anatomical levels C2-C3, C3-C4, C4-C5, C5-C6 and C6-C7 to compute the aforementioned DTI parameters. The ROIs were designed by neuroradiologist and neurosurgeon (MB and GI), including both the white matter and the grey matter and excluding the cerebrospinal fluid (CSF), as described by Thurnher et al. [31].

### *2.3. Measurement of Dexterity and Hand Strength*

The Nine-Hole Peg Test (NHPT) was used to assess the "digital dexterity" of the hand. Each subject performed "fine" grasping movement of nine pegs and released them in a wooden base. Once this phase was completed, the patient was instructed to remove each peg one by one, with the same hand. The test ended when all the pegs were placed inside the lid. The patients repeated the test twice for each hand and the average execution time was taken as result [32].

"Jamar" type digital dynamometer was used to measure the hand strength. The patient was instructed to sit down with the trunk in a neutral position, with the abducted shoulders aligned with each other on the frontal plane, the elbow flexed at 90◦, the forearm in a neutral position, the wrist in extension between 0◦ and 20◦ and with an ulnar deviation between 0◦ and 15◦. The dynamometer was supported by the operator's hand to prevent possible loss of strength by the patient. Using the same setting, for the dexterity assessment the patients performed two tests and then the average value was taken as result. The first rehearsal was conducted with the dominant limb (right for all the patients) [33] (Figure 1). All these tests were performed 24–48 h before and three months after surgery.

**Figure 1.** On the left: Nine-Hole Peg Test (NHPT). On the right: digital dynamometer (Camry EH101).

### *2.4. Statistical Analysis*

Data were analyzed using a paired *t*-test to compare the preoperative and postoperative Fractional Anisotropy values, dexterity and hand strength. A Pearson correlation analysis was then performed to assess the correlation between the postoperative FA values, strength and hand dexterity. A *p*-value < 0.05 was considered to be statistically significant.

#### **3. Results**

#### *3.1. Baseline Characteristics*

All patients underwent anterior cervical discectomy and fusion (ACDF) at 1 or 2 cervical levels. Eight patients (72.7%) showed high signal intensity (HSI) on T2WI; the mean mJOA score was 13.27 ± 2.61, therefore moderate myelopathy has been diagnosed in most patients (Table 1).

**Table 1.** Demographic, MRI characteristics and surgical level.

F: female; M: male; mJOA: modified Japanese Orthopedic Association score.

### *3.2. Di*ff*usion Tensor Imaging (DTI)*

The preoperative FA values were pathological (<0.68 ± 0.05 according to [20,21]) only at C6/C7 level, mostly below the frequently compromised level (Table 2). A significant increase in FA values after surgery was found at C5/C6 and C6/C7 level (paired *t*-test, *p* = 0.005 and *p* = 0.002 respectively) (Figure 2).

**Table 2.** Fractional anisotropy (FA) values of the anatomical level.

**Figure 2.** Fractional anisotropy (FA) values. Data are shown as mean values. The FA corresponding to the pre-surgery evaluation are shown in blue, whereas the FA corresponding to the post-surgery evaluation are shown in orange. Significant differences are shown with \* (*p* < 0.05).

We computed the FA values in correspondence of the most compressed anatomical level, which was the target of the surgery, and also in the anatomical levels immediately above and below.

The preoperative FA value was pathological (Table 3) below the most compressed level; in fact, a statistically significant increase of FA postoperatively was observed at the lower level (*p* = 0.044). (Figure 3).

**Figure 3.** FA values of the most compressed level, the site of surgery, and the anatomical levels immediately above and below. Data are shown as mean values. The FA corresponding to the pre-surgery evaluation are shown in blue, whereas the FA corresponding to the post-surgery evaluation are shown in orange. Significant differences are shown with \* (*p* < 0.05).

### *3.3. Dexterity and Hand Strength*

During the preoperative and postoperative evaluations, the mean values of hand "dexterity" were 28.8 and 25.6 s for the right hand, respectively, and 29 and 24.5 s for the left hand, respectively (Table 4). There was a significant improvement of hand "dexterity" (*p* = 0.002) for the left hand with a 15.4% reduction in the time needed for completing the task, while for the right hand, the improvement was not statistically significant (*p* = 0.057) (Figure 4).

Furthermore, the mean values of right hand strength were 26.2 vs. 27.4 kg, while the mean values of left hand strength were 24.4 and 25.7 kg (Table 4); no significant improvement of the postoperative strength was found for both hands (*p* = 0.055 and 0.068) (Figure 5).

**Table 4.** Measurement of dexterity and hand strength. The percentage of improvements for NHPT and hand strength was reported in green.

**Figure 4.** The average values of hand dexterity corresponding to the pre-surgery evaluation are shown in blue, whereas the values of hand dexterity corresponding to the post-surgery evaluation are shown in orange, distinguishing between right and left hand.

**Figure 5.** The average values of hand strength corresponding to the pre-surgery evaluation are shown in blue, whereas the values of hand strength corresponding to the post-surgery evaluation are shown in orange, distinguishing between right and left hand.

### *3.4. Correlation between the Postoperative FA Values and Strength and Hand Dexterity*

A weak linear correlation between the postoperative FA values measured at lower surgical level and the dexterity scores was observed; indeed, the time to perform fine grasping task was inversely proportional to the FA value (Pearson coefficient r = 0.4272, coefficient of determination R2 = 0.0735, *p*-value = 0.19 for the right hand; r = 0.2087, R2 = 0.2265, *p*-value = 0.53 for the left hand) (Figure 6).

**Figure 6.** Correlation between the postoperative FA values and hand dexterity.

The FA values were also positively correlated with the postoperative hand strength data: There was a weak correlation between the two variables, so that the higher were the FA values, the higher was the strength of each hand (r = −0.0216, R2 = 0.0068, *p*-value = 0.95 for the right hand; r = 0.0035 R2 = 0.0376, *p*-value = 0.99 for the left hand) (Figure 7).

**Figure 7.** Correlation between the postoperative FA values and hand strength.

#### **4. Discussion**

Degenerative cervical myelopathy (DCM) is an insidiously progressive condition, usually showing a chronic course of clinical symptoms: impairment of gait, weakness, spasticity, clumsy hands, and sphincter disorders [1–7]. Conventional MR examination has played a key role in the diagnosis of cervical spondylosis, proving hypertrophy of the posterior longitudinal ligament and ligament flavum, cervical disc herniation, and cervical spinal stenosis. The compressed part of the spinal cord shows a specific high signal intensity (HSI) on T2WI. T2 HSI is often used to diagnose DCM, but this finding is not observed in each patient with clinical signs of myelopathy and its sensitivity is reported to be quite low (between 15% and 65%). Additionally, T2 HSI is generally observed only in the later stages of the disease [12–17]. A promising MR technique, diffusion tensor imaging (DTI), has been investigated for estimating the neural tissue integrity in spinal cord. As compared to conventional MR imaging, DTI parameters are more sensitive in detecting DCM, especially at the early stages [18–26] and they might represent a helpful tool for educating and monitoring subjects with asymptomatic spinal cord compression [34].

Unlike free water, water molecule diffusion in human is hindered by cell alignment pattern, cell membranes and other intracellular and extracellular structures showing anisotropy. Fractional anisotropy (FA) measures the tendency of water to spread in a preferred direction within a group of axons. It is a function of the axonal density and integrity of white matter fibers, as well as of their degree of myelination [35]. A decrease of FA corresponds to a damage of pyramidal tracts; in fact its value is significantly reduced in DCM patients, as compared to healthy subjects [20]. In our sample, the FA value was pathological (<0.68 ± 0.05 [21,22]) only below the most compressed level, i.e., below the segment approached surgically. It is also important to recognize that FA measures at the site of compression are sometimes difficult to obtain particularly in patients with considerable cord compression. We observed a significant increase in FA values in the postoperative course at the level just below the most compressed one, supporting that this parameter depicts a structural damage of the descending pyramidal pathways. This finding proves that DCM-associated demyelination and axonal damage afflicted both the myelopathic lesion and the distal sites over the chronic course of the disease [2].

Recent studies demonstrated a strong correlation between FA and specific clinical assessments, including mJOA score [17–26]. Shen et al. [23] showed that the mJOA score is a reasonable predictor of surgical outcome in DCM; nonetheless, a model inclusive of FA value provides superior predictive ability. Rajasekaran et al. claimed that a postoperative worsening of DTI indices is associated with a poor prognosis for neurological recovery [36]. Dong et al. [20] asserted that FA value of spinal cord was associated with postoperative recovery of spinal cord function and that DTI may play a significant role in diagnosing and predicting the development of DCM. The patients with severe DCM, who presented a higher FA value at the compressed level, were most likely to achieve a better functional recovery after decompression surgery [37]. This might identify FA as a potential positive predicting factor of postoperative outcomes: Therefore, DTI could be considered not only a complementary diagnostic analysis, but rather a crucial tool in order to identify the best candidates to surgery [38].

In particular, our study focused on one of the most common disorders in DCM patients: The myelopathy hand. Finger disability is a typical sign of degeneration of the corticospinal tracts and occurs only in patients with spinal cord lesions above C6-C7 level [9,10]. Doita et al. [39] showed a good correlation between the more severe cervical myelopathy and the loss of hand dexterity; Murphy et al. [40] demonstrated a strong correlation between the Nine-Hole Peg Test (NHPT) and FA values, showing that patients with moderate myelopathy performed the test in a longer time as compared to the control cases. The hand strength significantly differs between healthy subjects and myelopathic patients and its value is often influenced by age and sex.

Our patients show a more evident impairment of hand function in performing a precision grip, as assessed by the NHPT, a specific test which is regularly performed to evaluate manual dexterity in patients with multiple sclerosis and which was previously used to distinguish healthy subjects from patients with DCM. The hand "dexterity" was improved three months after surgery (11.1% for the right hand (Patient 1; 2; 4; 5; 6; 7; 10; 11), 15.4% for the left hand (Patient 1; 2; 3; 4; 5; 6; 7; 8; 10; 11)), with a moderate correlation between postoperative FA values and dexterity data; therefore, the time to carry out the test was reduced as FA values increase. The hand strength measured using a digital dynamometer showed a slight improvement at postoperative follow-up (4.4% for the right hand, 5.4% for the left hand); however, it was weakly associated with postoperative FA values.

In these patients, the damage of the corticospinal tracts determines a finger "spasticity", which is evident when the patient is asked to reopen the hand previously forcibly closed with abnormal prolongation of voluntary de-contracting. Spasticity represents a complex clinical sign that greatly compromises the hand dexterity and the ability in performing voluntary movements in myelopathic patients [41].

Our results confirmed that FA can be claimed as a marker of myelopathy presenting both diagnostic and potential prognostic value in patient affected by DCM, as depicting the functional status of the spinal cord. Indeed, surgical decompression can improve the clinical outcomes of these patients, especially in terms of control of "fine" grasping.

Nevertheless, our study has several limitations. First, the MRI scanner used is 1.5 T, which has a good enough resolution for DTI analysis, even though 3 T scanners can have better performance. The lack of a gold standard for the diagnostic imaging of DCM and the current high standard technical requirements for diffusion weighted imaging could represent the biases of this research. Finally, another limitation of the study is the relatively small sample size of our patients.

### **5. Conclusions**

The diagnosis of degenerative cervical myelopathy includes a complex clinical picture: The patient's history, imaging and neurological status. The introduction of DTI allowed detecting spinal cord damage even at the earlier myelopathy stages, compared to the T2-weighted MR features. The combination of advanced imaging methods and diagnostic clinical tests for "Clumsy Hand" can help to accurately select the patients to be treated surgically and also to provide promising details in terms of predicting the outcomes. Further studies with larger case series and longer follow-up are needed to validate our results.

**Author Contributions:** Conceptualization: S.d., M.C.; G.I.; Data curation, F.R., M.B. and O.d.D.; formal analysis, F.R., M.B. and O.d.D.; methodology, L.P., G.P., F.R. and M.B.; software, L.P.; project administration, S.d., M.C., P.C. and G.I.; software, L.P., G.P.; supervision, D.S., T.S., P.C. and G.I.; validation, L.P. and G.P.; writing—original draft, S.d. and M.C.; writing—review and editing, S.d., M.C., L.P., G.P., D.S., T.S., P.C. and G.I. All authors have read and agree to the published version of the manuscript.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflicts of interest.

### **References**

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

### *Article*